Publications Office of the EU
Open framework agreement on pharmaceutical discounts pursuant to § 130a(8) SGB V with the possibility of accession at any time, so-called marketing authorisation model 2025-10 - EU tenders
DisplayCustomHeader
Procurement Detail Actions Portlet
OP Portal - Procurement - Details

This page contains content generated automatically to improve findability and accessibility

- indicates text translated automatically in your browsing language

Open framework agreement on pharmaceutical discounts pursuant to § 130a(8) SGB V with the possibility of accession at any time, so-called marketing authorisation model 2025-10 Text automatically translated in your browsing language Automatically translated

  • Published
    13/10/2025
  • Today
    07/11/2025
  • Deadline
    05/10/2027
Status
Published
Type of contract
Supplies
Subject for Renewal
No
Buyer
Deutsche Rentenversicherung Knappschaft-Bahn-See
Place of performance
NUTS code: Multiple place of performance
Location of buyer
NUTS code: DEA51 Bochum, Kreisfreie Stadt
Business sector (Main CPV)
33600000 Pharmaceutical products
Total estimated contract value (excluding VAT)
Not available
Total final contract value (excluding VAT)
Not available
Number of lots
6
Tender reference number
2.512.819
Description

This notice is intended to conclude agreements with pharmaceutical companies within the meaning of Section 130a(8) sentence 1 SGB V. The invitation to participate is addressed only to pharmaceutical entrepreneurs or employee groups of pharmaceutical entrepreneurs within the meaning of Section 4(18) of the German Medicines Act. It is not an open procedure pursuant to § 15 VgV in conjunction with § 119(3) GWB, but a publication of the invitation to conclude/join/discount contracts with conditions that are fixed and non-negotiable for all participants, including the amount of the discount. Contractual partners may become an unlimited number of pharmaceutical entrepreneurs or employee groups of pharmaceutical entrepreneurs within the meaning of Section 4(18) of the Pharmaceuticals Act. Text automatically translated in your browsing language Automatically translated

Submission Method
Electronic via:
https://www.kbs.de/DE/UeberUns/Ausschreibungen/EU/EU_node.html
Tenders may be submitted
Electronic submission: allowed
https://www.kbs.de/DE/UeberUns/Ausschreibungen/EU/EU_node.html
Information about a public contract, a framework agreement or a dynamic purchasing system (DPS)
The procurement involves the establishment of a framework agreement
Conditions for opening tenders (date)
Not available
Prior information
Contract
Award
Footnote - legal notice

This content published on this page is meant purely as an additional service and has no legal effect. The Union's institutions do not assume any liability for its contents. The official versions of the relevant tendering notices are those published in the Supplement of Official Journal of the European Union and available in TED. Those official texts are directly accessible through the links embedded in this page. For more information please see Public Procurement Explainability and Liability notice.